Narasimhan Agaram
Overview
Explore the profile of Narasimhan Agaram including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torrence D, Dermawan J, Zhang Y, Vanderbilt C, Hwang S, Mullaney K, et al.
Histopathology
. 2024 Jun;
85(6):889-898.
PMID: 38890779
Aims: Chondromyxoid fibroma (CMF) is a rare, benign bone tumour which arises primarily in young adults and is occasionally diagnostically challenging. Glutamate metabotropic receptor 1 (GRM1) gene encodes a metabotropic...
2.
Lahori M, Dehghani A, Wilson C, Law W, Agaram N, Murali R, et al.
Cytojournal
. 2023 Oct;
20:29.
PMID: 37810439
Objectives: Epithelioid hemangioendothelioma (EHE) is a vascular tumor of intermediate malignant potential, which presents as infiltrative lesions involving multiple organs. We reviewed our institutional experience with the cytologic diagnosis of...
3.
Sigel C, Wei X, Agaram N, Sigel K, Raza R, Andrade R, et al.
Cancer Cytopathol
. 2023 Jan;
131(5):325-336.
PMID: 36650420
Background: Pancreatic cyst cytology evaluates for neoplastic mucin and epithelial grade. This study describes cytological features of low- and high-grade mucinous neoplasms (MNs) using gastrointestinal contaminants for comparison. Methods: Histologically...
4.
Gounder M, Rosenbaum E, Wu N, Dickson M, Sheikh T, DAngelo S, et al.
Clin Cancer Res
. 2022 Feb;
28(8):1586-1594.
PMID: 35110418
Purpose: Because the Hedgehog and Notch pathways are often overexpressed in mesenchymal malignancies, we evaluated the efficacy of concurrent inhibition of Notch and Hedgehog signaling using the gamma-secretase inhibitor (GSI)...
5.
Zhang L, Hwang S, Benayed R, Zhu G, Mullaney K, Rios K, et al.
Mod Pathol
. 2020 Mar;
33(8):1492-1504.
PMID: 32157177
Herein we described the clinical, radiological, histological, and molecular characteristics of seven soft tissue aneurysmal bone cysts (STABCs) diagnosed and managed at a tertiary cancer center and to elucidate their...
6.
Zhu G, Nafa K, Agaram N, Zehir A, Benayed R, Sadowska J, et al.
Clin Cancer Res
. 2019 Oct;
26(2):419-427.
PMID: 31615936
Purpose: Chondrosarcomas are the second most common primary malignant bone tumors. Although histologic grade is the most important factor predicting the clinical outcome of chondrosarcoma, it is subject to interobserver...
7.
Okada T, Lee A, Qin L, Agaram N, Mimae T, Shen Y, et al.
Cancer Discov
. 2016 Sep;
6(10):1148-1165.
PMID: 27577794
Significance: Identifying the molecular pathogenesis for myxofibrosarcoma progression has proven challenging given the highly complex genomic alterations in this tumor type. We found that integrin-α10 promotes tumor cell survival through...
8.
Mathias M, Chou A, Meyers P, Shukla N, Hameed M, Agaram N, et al.
J Pediatr Hematol Oncol
. 2016 Jun;
38(5):e166-8.
PMID: 27352193
Poorly differentiated round cell sarcomas present diagnostic challenges because of their variable morphology and lack of specific immunophenotypic markers. We present a case of a 15-year-old female with a tibial...
9.
Sarungbam J, Agaram N, Hwang S, Lu C, Wang L, Healey J, et al.
Skeletal Radiol
. 2016 Mar;
45(7):929-35.
PMID: 27020452
Objective: Giant cell tumor of bone (GCTB) is a locally aggressive primary bone tumor. Its malignant counterpart is quite rare. Rarely, a conventional GCTB shows marked nuclear atypia, referred to...
10.
Gounder M, Desai V, Kuk D, Agaram N, Arcila M, Durham B, et al.
Eur J Cancer
. 2015 Aug;
51(16):2413-22.
PMID: 26298731
Background: Neoplasms of histiocytic and dendritic cell origin, including follicular dendritic cell sarcoma (FDCS), histiocytic sarcoma (HS) and interdigitating dendritic cell sarcoma (IDCS), are extremely rare, and data on their...